ITMCTR2000003332尚未招募1 期
Randomized, open, parallel controlled clinical study of Haiai Decoction combined with oral administration of finasteride for male androgenic alopecia
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- Male
入选标准
- •1. The typical clinical manifestations were in accordance with the diagnosis of AGA, and the degree of hair loss was in accordance with the BASP classification of androgenic hair loss;
- •2. In general, patients with good condition (no previous heart, systemic or scalp diseases) have not used any drugs that may affect hair growth (antihypertensive drugs, hormones, cytotoxic drugs, anti androgen drugs, etc.) within the first 3 months of the study;
- •3. Patients who agree to participate in observation and follow-up, are willing to receive follow-up, and can cooperate closely in the whole process.
排除标准
- •1. Finasteride was taken orally 18 months before the start of the experiment;
- •2. Use local or systemic drugs that affect hair growth within 12 months;
- •3. History of hair transplantation;
- •4. Systemic or scalp diseases that may affect hair growth.
研究者
相似试验
招募中
4 期
A randomized, open, parallel-controlled clinical trial on the efficacy and safety of Jingyebaidu granules in treating novel coronavirus pneumonia (COVID-19)ITMCTR2000002999Tongji Hospital, Tongji Medical College of HUST
尚未招募
不适用
A clinical trial to study the effects of two drugs Bortezomib (Biosyntez Laboratories Private Limited, India) and Bortenat (Natco Pharma Ltd., India) in patients with newly diagnosed multiple myeloma.CTRI/2013/12/004186RCI Syntez CJSC Russia60
进行中（未招募）
3 期
Study of Azacitidine in patients with a type of blood cancerCTRI/2012/07/002836ATCO Pharma Limited
尚未招募
2 期
A CLINICAL TRIAL TO STUDY KANER KSHARSUTRA IN THE TREATMENT OF BHAGANDARA.CTRI/2020/11/029087Dr Sapna Pawar
进行中（未招募）
1 期
clinical study on the efficacy of infiltrative echo-guided therapy with hyaluronic acid (500-730 KDa) (HYALGAN®) versus saline solution in the conservative treatment of Achilles tendinopathy. Subjects will be randomly assigned to one of these two groups of treatment. Both evaluator and patients are unaware of the treatment assigned. In the open label extension, patients with persistent pain can receive a second cycle of Hyalgan.Achilles tendinopathyEUCTR2013-004117-40-ITFidia Farmaceutici SpA54